OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dendritic Cell Tumor Vaccination via Fc Gamma Receptor Targeting: Lessons Learned from Pre-Clinical and Translational Studies
Enrique Gómez Alcaide, Sinduya Krishnarajah, Fabian Junker
Vaccines (2021) Vol. 9, Iss. 4, pp. 409-409
Open Access | Times Cited: 7
Enrique Gómez Alcaide, Sinduya Krishnarajah, Fabian Junker
Vaccines (2021) Vol. 9, Iss. 4, pp. 409-409
Open Access | Times Cited: 7
Showing 7 citing articles:
Large‐Sized Graphene Oxide Nanosheets Increase DC–T‐Cell Synaptic Contact and the Efficacy of DC Vaccines against SARS‐CoV‐2
Qianqian Zhou, Hongjing Gu, Sujing Sun, et al.
Advanced Materials (2021) Vol. 33, Iss. 40
Open Access | Times Cited: 44
Qianqian Zhou, Hongjing Gu, Sujing Sun, et al.
Advanced Materials (2021) Vol. 33, Iss. 40
Open Access | Times Cited: 44
Cell-targeted vaccines: implications for adaptive immunity
Trevor Ung, Nakisha S. Rutledge, Adam M. Weiss, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Trevor Ung, Nakisha S. Rutledge, Adam M. Weiss, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Altering Landscape of Cancer Vaccines: Unique Platforms, Research on Therapeutic Applications and Recent Patents
Suman Kumar Ray, Sukhes Mukherjee
Recent Patents on Anti-Cancer Drug Discovery (2022) Vol. 18, Iss. 2, pp. 133-146
Closed Access | Times Cited: 4
Suman Kumar Ray, Sukhes Mukherjee
Recent Patents on Anti-Cancer Drug Discovery (2022) Vol. 18, Iss. 2, pp. 133-146
Closed Access | Times Cited: 4
Perspective view of allogeneic IgG tumor immunotherapy
Ying Liu, Yuanyi Huang, Hongwei Cui, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access
Ying Liu, Yuanyi Huang, Hongwei Cui, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access
Recent Advances in Antitumor Dendritic Cell Vaccines
Chunxia Ge, Xuelian Yang, Jiaxuan Xin, et al.
Cancer Biotherapy and Radiopharmaceuticals (2023) Vol. 38, Iss. 7, pp. 450-457
Closed Access | Times Cited: 1
Chunxia Ge, Xuelian Yang, Jiaxuan Xin, et al.
Cancer Biotherapy and Radiopharmaceuticals (2023) Vol. 38, Iss. 7, pp. 450-457
Closed Access | Times Cited: 1
Molecular and Clinical Aspects of COVID-19 Vaccines and Other Therapeutic Interventions Apropos Emerging Variants of Concern
Khursheed Ul Islam, Thoraya Mohamed Elhassan A-Elgadir, Sarah Afaq, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 2
Khursheed Ul Islam, Thoraya Mohamed Elhassan A-Elgadir, Sarah Afaq, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 2
CpG-ODN Signaling via Dendritic Cells-Expressing MyD88, but Not IL-10, Inhibits Allergic Sensitization
Ricardo Wesley Alberca, E. Gomes, Momtchilo Russo
Vaccines (2021) Vol. 9, Iss. 7, pp. 743-743
Open Access | Times Cited: 1
Ricardo Wesley Alberca, E. Gomes, Momtchilo Russo
Vaccines (2021) Vol. 9, Iss. 7, pp. 743-743
Open Access | Times Cited: 1
